JP2010510218A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510218A5
JP2010510218A5 JP2009537218A JP2009537218A JP2010510218A5 JP 2010510218 A5 JP2010510218 A5 JP 2010510218A5 JP 2009537218 A JP2009537218 A JP 2009537218A JP 2009537218 A JP2009537218 A JP 2009537218A JP 2010510218 A5 JP2010510218 A5 JP 2010510218A5
Authority
JP
Japan
Prior art keywords
tissue
mammal
composition
administration
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009537218A
Other languages
English (en)
Japanese (ja)
Other versions
JP5646851B2 (ja
JP2010510218A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/024051 external-priority patent/WO2008063555A2/en
Publication of JP2010510218A publication Critical patent/JP2010510218A/ja
Publication of JP2010510218A5 publication Critical patent/JP2010510218A5/ja
Application granted granted Critical
Publication of JP5646851B2 publication Critical patent/JP5646851B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009537218A 2006-11-17 2007-11-16 エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法 Active JP5646851B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85972406P 2006-11-17 2006-11-17
US60/859,724 2006-11-17
PCT/US2007/024051 WO2008063555A2 (en) 2006-11-17 2007-11-16 Methods of enhancing immune response using electroporation-assisted vaccination and boosting

Publications (3)

Publication Number Publication Date
JP2010510218A JP2010510218A (ja) 2010-04-02
JP2010510218A5 true JP2010510218A5 (enExample) 2010-11-25
JP5646851B2 JP5646851B2 (ja) 2014-12-24

Family

ID=39430332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537218A Active JP5646851B2 (ja) 2006-11-17 2007-11-16 エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法

Country Status (8)

Country Link
US (1) US20100285040A1 (enExample)
EP (1) EP2091558B1 (enExample)
JP (1) JP5646851B2 (enExample)
KR (1) KR20090080941A (enExample)
CN (1) CN101522211A (enExample)
AU (1) AU2007322075B2 (enExample)
CA (1) CA2668649A1 (enExample)
WO (1) WO2008063555A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010148440A1 (en) 2009-06-24 2010-12-29 International Scientific Pty Ltd An apparatus and method of treatment utilizing a varying electromagnetic energisation profile
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US118956A (en) * 1871-09-12 Improvement in apparatus for the manufacture of extracts from hemlock and other
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US6009345A (en) 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
US6110161A (en) 1997-04-03 2000-08-29 Electrofect As Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
TW368420B (en) 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
US6972013B1 (en) 1998-07-13 2005-12-06 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
EP1148885A4 (en) * 1999-02-08 2002-05-08 Chiron Corp ELECTRICALLY INDUCED INCREASE IN IMMUNITY AND EFFECTIVENESS OF IN VIVO DNA VACCINES
US7171264B1 (en) * 1999-05-10 2007-01-30 Genetronics, Inc. Intradermal delivery of active agents by needle-free injection and electroporation
GB9922361D0 (en) * 1999-09-21 1999-11-24 Isis Innovation Generating an immune response to an antigen
ES2386884T3 (es) * 2000-11-01 2012-09-04 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vectores de expresión capaces de inducir respuesta inmunomejorada y métodos para usarlos
CA2478614C (en) 2001-03-13 2013-01-15 University Of South Florida Electromanipulation device and method
WO2003072016A2 (en) * 2001-11-19 2003-09-04 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
EP1474153A4 (en) * 2001-12-14 2005-12-14 Genetronics Inc PARTICLE-ASSISTED IMMUNIZATION METHODS BASED ON THE USE OF A PULSE ELECTRIC FIELD
US20060035853A1 (en) * 2004-01-07 2006-02-16 Biomedical Research Models, Inc. Methods for tailoring the immune response to an antigen or immunogen
EP1981581B1 (en) 2006-02-11 2016-04-13 Genetronics, Inc. Device for single-needle in vivo electroporation

Similar Documents

Publication Publication Date Title
Bal et al. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
RU2016106134A (ru) Иммуногенные противовоспалительные композиции
MX2021001762A (es) Metodo y composicion para estimular la respuesta inmunitaria.
US20180015161A1 (en) Checkpoint Inhibitor and Vaccine Combinations and Use of Same For Immunotherapy
WO2012027379A3 (en) Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
MX2016002152A (es) Metodo para aumentar la expresion de proteinas codificadas por arn.
Yan et al. Enhancement of Ag85B DNA vaccine immunogenicity against tuberculosis by dissolving microneedles in mice
JP2012529488A5 (enExample)
ME02662B (me) Niskofrekventna terapija glatiramer acetatom
NZ630790A (en) Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
FI3501534T3 (fi) Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia
WO2009089535A3 (en) Polypeptide vaccine and vaccination strategy against mycobacterium
JP2015520196A5 (enExample)
NZ628328A (en) Rna formulation for immunotherapy
Shakya et al. Microneedle-mediated allergen-specific immunotherapy for the treatment of airway allergy in mice
JP2016516016A5 (enExample)
JP2016520089A5 (enExample)
JP2015533376A5 (enExample)
JP2014513722A5 (enExample)
CN104168912A (zh) 促进剂-dna组合疫苗
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
RU2015116264A (ru) Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
JP2018536002A5 (enExample)
JP2010510218A5 (enExample)
JP2013523886A5 (enExample)